Shortlysts logo
Shortlysts
About Us
Subscribe
  • Shortlysts
  • Topics
  • FDA

FDA

TeslaShippingCovidSenateGun controlSouth KoreaTrumpCanadaChinaHackingGasPanama CanalFBIRadical Gender IdeologyElon MuskGermanyAbortionCommoditiesNorth KoreaLebanonCaliforniaGreen EnergyMiddle EastWagesNPRMedicaidHarvardSaudi ArabiaBiotechnologyU.S. PoliticsCongressCyber WarfareInflationTechPublic transitUS Postal ServiceOilScienceTsunamiEnergyAmazonFederal ReserveEuropeNew York CityMedicineUkraineIsraelBanksDOGERepublican PartyMilitarySupreme CourtMexicoCharlie KirkHealthSyriaMetaPakistanIndiaHousingBritainVotingTexasNobel PrizeDronesTurkeyH1BAIEarthquakeDebtWarImmigrationAuto IndustryOpioidsFentanylCryptocurrencyDEISteelANTIFATrade UnionsDemocratic PartyGeopoliticsTechnologyTylenolRFK JrKey MineralsPolandPop CultureRussiaEducationSecond AmendmentPropertyGoldUnited KingdomNASADonald TrumpMoonEconomyRobotsDroneBitcoinJobsSECUSAIDTerrorismCambodiaAviationTransgenderNvidiaTrudeauGovernmentPutinSpaceU.K.MediaNuclear energyIRSInvestmentTariffsIranPoliceJoe BidenCrimeOPECCNNWild FiresPopeDARPAThailandAsiaGreenlandAustraliaFDACIABudgetFacebookIllegal AliensUSATreasurySocial SecurityGoogleMedicareJapanRetailCensorshipFloodsDrugsAppleSuper BowlInterest RatesDepartment of TransportNational SecurityStocksVaccineNATOTikTok
FDAFDA
Red State Rebellion: Louisiana Takes the FDA to Court Over Abortion Drug Access
Oct 10, 2025

Red State Rebellion: Louisiana Takes the FDA to Court Over Abortion Drug Access

Louisiana sues the FDA over abortion pills by mail, testing the limits of state power, federal oversight, and legal grey areas.

Tyler Flores
Tyler Flores
AbortionAbortion
+2+2
Food and Drug Administration Approves Generic Version of Mifepristone
Oct 06, 2025

Food and Drug Administration Approves Generic Version of Mifepristone

United States Food and Drug Administration approve a generic version of the drug mifepristone.

Jason Belcher
Jason Belcher
FDAFDA
FDA Clears Cheaper Abortion Pill as Access Fight Continues
Oct 03, 2025

FDA Clears Cheaper Abortion Pill as Access Fight Continues

The FDA approved the first generic abortion pill, lowering costs in legal states and fueling new political battles.

Tyler Flores
Tyler Flores
FDAFDA
+1+1
Trump Administration Targets Pharmaceutical Ads in Major FDA Crackdown
Sep 11, 2025

Trump Administration Targets Pharmaceutical Ads in Major FDA Crackdown

The FDA is cracking down on misleading drug ads, forcing companies to include clear safety info in every consumer message.

Tyler Flores
Tyler Flores
HealthHealth
+1+1
FDA Is Now an Open Book: RFK Jr. Forces FDA Into the Open
Aug 25, 2025

FDA Is Now an Open Book: RFK Jr. Forces FDA Into the Open

RFK Jr.’s FDA now posts real-time drug safety reports, cutting red tape and putting health data directly into public hands.

Tyler Flores
Tyler Flores
CovidCovid
+3+3
The Great Walk-Back: FDA Backs Off Annual COVID Shots for the Young and Healthy
May 21, 2025

The Great Walk-Back: FDA Backs Off Annual COVID Shots for the Young and Healthy

The FDA has just reversed course on annual COVID shots for healthy individuals, acknowledging what critics have said for years: not everyone needs the booster.

Tyler Flores
Tyler Flores
MedicineMedicine
+2+2
Fluoride Fallout: FDA Cracks Down on Fluoride for Kids
May 19, 2025

Fluoride Fallout: FDA Cracks Down on Fluoride for Kids

The FDA is pulling kids’ fluoride pills over links to IQ loss and thyroid issues, sparking a debate on dental health and safety.

Tyler Flores
Tyler Flores
OpioidsOpioids
+1+1
FDA Approves New Non-Opioid Painkiller
Feb 05, 2025

FDA Approves New Non-Opioid Painkiller

FDA approves first new pain medication in over a decade, authorizing the use of Journavx in the United States.

Jason Belcher
Jason Belcher
A lightning-fast read, packed with essentials, shortlists make it easy to stay informed, savvy and ready for your day.

Shortlysts

A lightning-fast read, packed with essentials, shortlists make it easy to stay informed, savvy and ready for your day.

Home

Posts

About Us

About Us

© 2025 Shortlysts.com. All Rights Reserved. Operated by Millionaire Marketing.

Privacy policy

Terms of use